Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Pharmacol Ther. 2017 Jun 22;180:139–143. doi: 10.1016/j.pharmthera.2017.06.012

Figure 1.

Figure 1

Diet and obesity may lead to dysregulated arginine metabolism and increase the production of advanced glycation end products (AGE) and subsequent activation of their receptor (RAGE), contributing to inflammation and asthma. The GLP-1 pathway may be critical to attenuating this inflammation.